Cargando…

Implications of COVID-19 for the management of patients with inflammatory rheumatic diseases

Detalles Bibliográficos
Autores principales:	Richez, Christophe, Lazaro, Estibaliz, Lemoine, Maël, Truchetet, Marie-Elise, Schaeverbeke, Thierry
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Société française de rhumatologie. Published by Elsevier Masson SAS. 2020
Materias:	Editorial
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7167224/ https://www.ncbi.nlm.nih.gov/pubmed/32321633 http://dx.doi.org/10.1016/j.jbspin.2020.03.010

Ejemplares similares

Implications du COVID-19 pour la prise en charge des rhumatismes inflammatoires chroniques()
por: Richez, Christophe, et al.
Publicado: (2020)

Clinical characteristics of rheumatic syndromes associated with checkpoint inhibitors therapy
por: Kostine, Marie, et al.
Publicado: (2019)

Abatacept monotherapy compared with abatacept plus disease-modifying anti-rheumatic drugs in rheumatoid arthritis patients: data from the ORA registry
por: Truchetet, Marie-Elise, et al.
Publicado: (2016)

Adult-onset Still’s disease biological treatment strategy may depend on the phenotypic dichotomy
por: Vercruysse, François, et al.
Publicado: (2019)

Outcome of COVID-19 in patients with rheumatic and inflammatory diseases treated with mycophenolic acid: data from the French RMD COVID-19 cohort
por: Truchetet, Marie-Elise, et al.
Publicado: (2022)

Locoregional Treatments for Digital Ulcers in Systemic Sclerosis: A Systematic Review
por: COSTEDOAT, Ingrid, et al.
Publicado: (2021)

Innate Immunity in Systemic Sclerosis Fibrosis: Recent Advances
por: Laurent, Paoline, et al.
Publicado: (2018)

Predictive biological markers of systemic lupus erythematosus flares: a systematic literature review
por: Gensous, Noémie, et al.
Publicado: (2017)

T Follicular Helper Cells in Autoimmune Disorders
por: Gensous, Noémie, et al.
Publicado: (2018)

Managing patients with rheumatic diseases during the COVID-19 pandemic: The French Society of Rheumatology answers to most frequently asked questions up to May 2020
por: Richez, Christophe, et al.
Publicado: (2020)

Microbiota Composition May Predict Anti-Tnf Alpha Response in Spondyloarthritis Patients: an Exploratory Study
por: Bazin, Thomas, et al.
Publicado: (2018)

Use of a bDMARD or tsDMARD for the management of inflammatory arthritis under checkpoint inhibitors: an observational study
por: De La Fuente, Fanny, et al.
Publicado: (2022)

Elevated Circulatory Levels of Microparticles Are Associated to Lung Fibrosis and Vasculopathy During Systemic Sclerosis
por: Leleu, Damien, et al.
Publicado: (2020)

Challenges of autoimmune rheumatic disease treatment during the COVID-19 pandemic: A review
por: Grange, Lucile, et al.
Publicado: (2020)

Immune related adverse events associated with anti-CTLA-4 antibodies: systematic review and meta-analysis
por: Bertrand, Anne, et al.
Publicado: (2015)

Protective Microbiota: From Localized to Long-Reaching Co-Immunity
por: Chiu, Lynn, et al.
Publicado: (2017)

TGFβ promotes low IL10-producing ILC2 with profibrotic ability involved in skin fibrosis in systemic sclerosis
por: Laurent, Paôline, et al.
Publicado: (2021)

Immune checkpoint inhibitor rechallenge in patients who previously experienced immune-related inflammatory arthritis: a multicentre observational study
por: Ladouceur, Alexandra, et al.
Publicado: (2023)

COVID-19 outcomes in patients with inflammatory rheumatic and musculoskeletal diseases treated with rituximab: a cohort study
por: Avouac, Jérôme, et al.
Publicado: (2021)

Myeloid dendritic cells correlate with clinical response whereas plasmacytoid dendritic cells impact autoantibody development in rheumatoid arthritis patients treated with infliximab
por: Richez, Christophe, et al.
Publicado: (2009)

COVID-19 – rheumatic diseases and rheumatologists
por: Maślińska, Maria
Publicado: (2021)

Implication of IL-17 in Bone Loss and Structural Damage in Inflammatory Rheumatic Diseases
por: Le Goff, Benoit, et al.
Publicado: (2019)

Vaccinations in autoimmune inflammatory rheumatic diseases
por: Szenborn, Leszek
Publicado: (2016)

Signal Transduction Pathways in Chronic Inflammatory Rheumatic Diseases
por: Cope, Andrew P
Publicado: (2012)

COVID-19, chronic inflammatory rheumatic disease and anti-rheumatic treatments
por: Ouédraogo, Dieu-Donné, et al.
Publicado: (2020)

COVID-19 presentation and outcomes in patients with inflammatory rheumatic and musculoskeletal diseases receiving IL6-receptor antagonists prior to SARS-CoV-2 infection
por: Comarmond, Cloé, et al.
Publicado: (2023)

CovAID: Identification of factors associated with severe COVID-19 in patients with inflammatory rheumatism or autoimmune diseases
por: Chevalier, Kevin, et al.
Publicado: (2023)

Vaccination of patients with autoimmune inflammatory rheumatic disease: physicians’ perspectives
por: Moon, Ki Won
Publicado: (2023)

Position of magnetic resonance in the imaging of inflammatory rheumatic diseases
por: Korkosz, Mariusz
Publicado: (2015)

The potential role of 'non-rheumatic’ therapies in rheumatic disease
por: Massarotti, Elena M, et al.
Publicado: (2013)

COVID-19 Among Patients With Inflammatory Rheumatic Diseases
por: Esatoglu, Sinem Nihal, et al.
Publicado: (2021)

COVID-19 vaccination in individuals with inflammatory rheumatic diseases
por: Skapenko, Alla, et al.
Publicado: (2022)

Update on COVID-19 vaccines and autoimmune-mediated rheumatic diseases
por: Suresh, Lakshmanan
Publicado: (2021)

Management of Patients With Inflammatory Rheumatic Diseases: Telemedicine and Rheumatologists Challenged in the Era of COVID-19
por: Foti, Rosario, et al.
Publicado: (2020)

Prise en charge des patients atteints de maladies rhumatismales pendant la pandémie de COVID-19 : la Société française de rhumatologie répond aux questions fréquentes posées jusqu’en mai 2020()
por: Richez, Christophe, et al.
Publicado: (2021)

Managing rheumatic diseases during COVID-19
por: Ladani, Amit P., et al.
Publicado: (2020)

Assessment of Evidence for COVID-19 and Rheumatic Diseases: Brief Considerations about Immunity and Pathophysiology
por: Jadali, Zohreh
Publicado: (2021)

Perspective: COVID-19, implications of nasal diseases and consequences for their management
por: Jian, Li, et al.
Publicado: (2020)

Autoimmune Rheumatic Diseases
por: Anaya, Juan-Manuel, et al.
Publicado: (2014)

Spine and Rheumatic Diseases
por: Wei, James Cheng-Chung, et al.
Publicado: (2015)

Cannot write session to /tmp/vufind_sessions/sess_43tepq1ed0nq7uo9cl4ckm00h5